Inkef — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBioGeneration VenturesBioMedPartnersEIR VenturesOxford Science Enterprises
Withlocals is an online marketplace that connects travelers with local hosts for private, personalized guided tours and food experiences in cities worldwide.
ConsumerMarketplacesTravel & Hospitality
Co-investorsKeen Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





